• Blau Farmacêutica's third-quarter 2026 net cash position reached BRL 98 million, versus net debt of BRL 197 million a year earlier.
• Cash and investments rose to BRL 1.01 billion from BRL 885 million in the previous quarter.
• Gross debt increased to BRL 910 million from BRL 821 million in the previous quarter.
• Working capital declined to BRL 867 million from BRL 907 million in the previous quarter.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Blau Farmaceutica SA published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.